Engineering Skin with Skinny Genes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28777938.
- Also identified by DOI 10.1016/j.stem.2017.07.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.
Medical subject headings
- Diabetes Mellitus, Type 2